Merrimack Pharmaceuticals, Inc. (MACK) Dividends

Merrimack Pharmaceuticals, Inc. (MACK): $6.19

-0.13 (-2.06%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MACK to Watchlist
Sign Up

Industry: Biotech


Ranked

of 495

in industry

Dividend Yield and Dividend History Highlights

  • MACK has a compound annual growth rate of its cash flow of -0.32%, higher than about 3.05% stocks in our dividend set.
  • MACK has an EBITDA to net debt ratio of -131,000; for context, that's better than 2.69% stocks in our set (note that its net debt is negative, meaning it has more cash than debt).
  • If you want to include this stock in your dividend portfolio, here are some dividend stocks that are NOT correlated with MACK that may be suitable potential portfolio mates: GAIA, HMG, ROP, SHLX and MUSA.

MACK does not currently pay a dividend. If the company does initiate a dividend payout, we'll add their payout info and history here.

In the mean time, you can check out our list of High Yield Dividend Stocks.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6337 seconds.